Suchergebnisse - (Subject:"O3J8G9O825")

PubPharm (5.514)

101

Enhanced tissue distribution of ritonavir-loaded nanostructured lipid carriers-recommending its dose reduction

enthalten in: Drug delivery and translational research | 2024

von Jitta, S. | Salwa | Bhaskaran, N. | +6

102

Paediatric abacavir-lamivudine fixed-dose dispersible tablets and ritonavir-boosted lopinavir granules in neonates exposed to HIV (PETITE study) : an open-label, two-stage, single-arm, phase 1/2, pharmacokinetic and safety trial

enthalten in: The lancet. HIV | 2024

von Bekker, A. | Salvadori, N. | Rabie, H. | +10

ErratumIn: Lancet HIV. 2024 Apr 5;:. - PMID 38588690

103

Drug-drug interactions between COVID-19 drug therapies and antidepressants

enthalten in: Expert opinion on drug metabolism & toxicology | 2023

von Davoutis, E. | Panou, C. | Stachika, N. | +2

104

Rebound of COVID-19 With Nirmatrelvir-Ritonavir Antiviral Therapy

enthalten in: Annals of internal medicine | 2023

von Cohen, M. | Brown, E.

CommentOn: Ann Intern Med. 2023 Dec;176(12):1577-1585. - PMID 37956428

105

Nirmatrelvir/ritonavir drug-drug interactions in primary care outpatients

enthalten in: Anales del sistema sanitario de Navarra | 2023

von Rodríguez Esquíroz, A. | Sanz Álvarez, L. | Marín Marín, M. | +3

106

Cost-effectiveness analysis of ritonavir boosted nirmatrelvir for adult outpatients with mild to moderate COVID-19 in a European health system

enthalten in: European journal of internal medicine | 2023

von Wikman-Jorgensen, P. | Ibarra, J. | Devesa, C. | +2

107

SARS-CoV-2 Rebound With and Without Use of COVID-19 Oral Antivirals

enthalten in: MMWR. Morbidity and mortality weekly report | 2023

von Smith, D. | Lambrou, A. | Patel, P.

108

Evaluation of SARS-CoV-2 RNA Rebound After Nirmatrelvir/Ritonavir Treatment in Randomized, Double-Blind, Placebo-Controlled Trials - United States and International Sites, 2021-2022

enthalten in: MMWR. Morbidity and mortality weekly report | 2023

von Harrington, P. | Cong, J. | Troy, S. | +6

109

Impact of Paxlovid on in-hospital outcomes and post-COVID-19 condition in adult patients infected with SARS-CoV-2 Omicron variant : A non-randomized controlled clinical trial

enthalten in: Medicine | 2023

von Xu, J. | Song, J. | Xie, Z. | +6

110

Long COVID and possible preventive options

enthalten in: Inflammopharmacology | 2023

von Sebők, S. | Gyires, K.